Funder
University of Medicine and Pharmacy Hospital, Hue University
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. IARC Helicobacter pylori Working Group (2014) Helicobacter pylori eradication as a strategy for preventing gastric cancer. Lyon, France: International Agency for Research on Cancer (IARC Working Group Reports, No 8).
2. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY (1999) Relationship between Helicobacter priori iceA, cagA, and vacA status and clinical outcome: Studies in four different countries. J Clin Microbiol 37(7):2274–2279
3. Imoto I, Oka S, Katsurahara M, Nakamura M, Yasuma T, Akada J, D’Alessandro-Gabazza CN, Toda M, Horiki N, Gabazza EC, Yamaoka Y (2022) Helicobacter pylori infection: is there circulating vacuolating cytotoxin A or cytotoxin-associated gene A protein? Gut Pathog 14:43
4. Jones KR, Whitmire JM, Merrell DS (2010) A tale of two toxins: Helicobacter pylori CagA and VacA modulate host pathways that impact disease. Front Microbiol 1:115
5. Hatakeyama M (2014) Helicobacter pylori CagA and gastric cancer: A paradigm for hit-and-run carcinogenesis. Cell Host Microbe 15(3):306–316